Arm Taiwan Act of 2021

Legislation regarding drug pricing, value, and reimbursement including implementation of the Inflation Reduction Act of 2022. The Safe Step Act, H.R. 2630/S. 652. The HELP Copays Act, H.R. 830/S. 1375. H.R. 5339/S 3131, the Optimizing Research Progress Hope and New Cures (ORPHAN Cures Act).

Client expense: $140,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Center for Medicare and Medicaid Innovation (CMMI) policy issues. Drug Pricing. General Medicare and Medicaid Issues. H.R.5376 - Inflation Reduction Act of 2022 implementation. S.476 /H.R.5547 - Maintaining Investments in New Innovation (MINI) Act. S.3131/H.R.5539 - ORPHAN Cures Act.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Center for Medicare and Medicaid Innovation (CMMI) policy issues. Drug Pricing. General Medicare and Medicaid Issues. H.R.5376 - Inflation Reduction Act of 2022 implementation. S.476 /H.R.5547 - Maintaining Investments in New Innovation Act. S.3131 / H.R.5539 - ORPHAN Cures Act.

Client expense: Not reported · Firm income: $50,000

Legislation regarding drug pricing, value, and reimbursement including implementation of the Inflation Reduction Act of 2022. The Safe Step Act, H.R. 2630/S. 652. The HELP Copays Act, H.R. 830/S. 1375. H.R. 5339/S 3131, the Optimizing Research Progress Hope and New Cures (ORPHAN Cures Act).

Client expense: $170,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Legislation regarding drug pricing, value, and reimbursement including implementation of the Inflation Reduction Act of 2022. The Safe Step Act, H.R. 2630/S. 652. The HELP Copays Act, H.R. 830/S. 1375. H.R. 5339/S 3131, the Optimizing Research Progress Hope and New Cures (ORPHAN Cures Act).

Client expense: $105,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 6329, National Critical Capabilities Defense Act of 2021, all provisions. H.R. 6443, Arm Taiwan Act of 2022, all provisions. H.R. 6833, Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023, (issues related to congressional oversight of U.S. foreign policy). H.R. 8259, Arms Exports Delivery Solutions Act, all provisions. H.R.5376, Inflation Reduction Act of 2022, (issues related to rare earths and critical minerals). H.R.7987, DEFEND Act of 2022, all provisions. S. 1854, National Critical Capabilities Defense Act of 2021, all provisions. S. 4554, Iran Nuclear Weapons Capability Monitoring Act of 2022, all provisions. S. 3131, Arm Taiwan Act of 2021, all provisions. S. 4190, Independent and Objective Oversight of Ukrainian Assistance Act, all provisions. S. 73, American Security Drone Act of 2021, all provisions. S.4366, DEFEND Act of 2022, all provisions. H.R. 7900, National Defense Authorization Act for Fiscal Year 2023, (issues related to Abraham Accords, Anti-Money Laundering, Arms Sales, Caesar Syria Civilian Protection Act, Chinas Global Infrastructure, Chinas Military-Civil Fusion Strategy, Chinese Commercial Networks, International and Multilateral Organizations, Iran in Latin America, Iran Sanctions, Iran Terrorism Accountability, IRGC Ownership, Missile Defense Cooperation in the Middle East, Rare Earth Elements, Reauthorization of the SHIELDS Act, Russia in Latin America, Russia/Iran Sanctions Evasion, Russian Energy, Safeguarding U.S. Government-Funded Research, Terror Groups' Use of Human Shields, U.S. Defense Supply Chain, U.S. Military Exercises in the Indo-Pacific, U.S. Military Exercises in the Middle East, U.S. Policy on China, U.S. Policy on China-Russia Ties, U.S. Policy on Iran, U.S. Policy on Russia, U.S. Sanctions Policy, U.S. Security Cooperation and Assistance, U.S.-Israel Operations-Technology Working Group, and Unmanned Aircraft Systems). S. 4543, James M. Inhofe National Defense Authorization Act for Fiscal Year 2023, (issues related to Abraham Accords, Anti-Money Laundering, Arms Sales, Caesar Syria Civilian Protection Act, Chinese Commercial Networks, Congressional Oversight of U.S. Foreign Policy, Foreign Malign Influence, Global Corruption, Implementation of Global Magnitsky, International and Multilateral Organizations, Iran Sanctions, Irans Foreign Policy and Military Strategy, Iranian Terrorism Accountability, IRGC Ownership, Missile Defense Cooperation in the Middle East, National Guard International Partnerships, Rare Earth Elements, Russia/Iran Sanctions Evasion, U.S. Defense Supply Chain, U.S. Higher Education, U.S. Pacific Islands Strategy, U.S. Policy on Hamas, U.S. Policy on Hezbollah, U.S. Policy on Russia, U.S. Policy on Syria, U.S. Policy on Taiwan, U.S. Security Cooperation and Assistance, U.S.-Israel Operations-Technology Working Group, Unmanned Aircraft Systems). Issues related to Abraham Accords, Chinas Military Strategy and Capabilities, Chinas Military-Civil Fusion Strategy, Chinese Commercial Networks, Chinese Influence Operations, International and Multilateral Organizations, Irans Foreign Policy and Military Strategy, Irans Military Strategy and Capabilities, Iranian Terrorism Accountability, Palestinian Politics and Terrorism, U.S. Defense Industrial Base & Supply Chain, U.S. Military Capabilities, U.S. Policy on Cyprus, U.S. Policy on Hezbollah, U.S. Policy on Iran, U.S. Policy on Israel, U.S. Policy on Lebanon, U.S. Policy on Russia, U.S. Policy on Syria, U.S. Policy on Taiwan, U.S. Policy on Ukraine, and U.S. Security Cooperation and Assistance (no bill).

H.R. 6329, National Critical Capabilities Defense Act of 2021, all provisions. H.R. 6443, Arm Taiwan Act of 2022, all provisions. H.R. 7855, Halting Academic Liaisons To (HALT) our Adversaries Act, all provisions. H.R. 7987, DEFEND Act of 2022, all provisions. H.R.7691, Additional Ukraine Supplemental Appropriations Act, 2022, all provisions. S. 1854, National Critical Capabilities Defense Act of 2021, all provisions. S. 3131, Arm Taiwan Act of 2021, all provisions. S. 4366, DEFEND Act of 2022, all provisions. S. 73, American Security Drone Act of 2021, all provisions. H.R. 7900, National Defense Authorization Act for Fiscal Year 2023, (issues related to Abraham Accords, Accelerating Arms Deliveries, Caesar Syria Civilian Protection Act, Chinas Global Shipping Networks, Chinese Military Companies Operations and Influence in the U.S., Chinese Military-Affiliated Universities, Counter-UAS System Capabilities, International and Multilateral Organizations, Iran in Latin America, Iran Sanctions, Iran Terrorism Accountability, IRGC Ownership, Missile Defense Cooperation in the Middle East, Money Laundering, Rare Earth Elements, Reauthorization of the SHIELDS Act, Russia in Latin America, Russia/Iran Sanctions Evasion, Russian Energy Dependency, Safeguarding U.S. Government-Funded Research, Terror Groups' Use of Human Shields, U.S. Defense Supply Chain, U.S. Military Exercises in the Indo-Pacific, U.S. Military Exercises in the Middle East, U.S. Policy on China, U.S. Policy on China-Russia Ties, U.S. Policy on Iran, U.S. Policy on Russia, U.S. Sanctions Policy, U.S. Security Cooperation and Assistance, U.S.-Israel Operations-Technology Working Group). S. 4543, James M. Inhofe National Defense Authorization Act for Fiscal Year 2023, (issues related to Abraham Accords, Accelerating Arms Deliveries, Caesar Syria Civilian Protection Act, Chinese Military Companies Operations and Influence in the U.S., Counter-UAS System Capabilities, International and Multilateral Organizations, Iran Sanctions, Iran Terrorism Accountability, IRGC Ownership, Missile Defense Cooperation in the Middle East, Money Laundering, National Guard International Partnerships, Rare Earth Elements, Russia/Iran Sanctions Evasion, U.S. Defense Supply Chain, U.S. Pacific Islands Strategy, U.S. Policy on Taiwan, U.S. Security Cooperation and Assistance). Issues related to Abraham Accords, Chinas Military Strategy and Capabilities, Chinese Influence Operations, Chinese Military Companies Operations and Influence in the U.S., Chinese Military-Civil Fusion Strategy, Implementation of the Sanctioning the Use of Civilians as Defenseless Shields Act, Irans Military Strategy and Capabilities, U.S. Arms Sales, U.S. Cybersecurity Strategy and Capabilities, U.S. Defense Industrial Base & Supply Chain, U.S. Policy on China, U.S. Policy on Iran, U.S. Policy on Israel, U.S. Policy on Lebanon, U.S. Policy on Russia, U.S. Policy on Taiwan, U.S. Policy on Turkey, U.S. Policy on Ukraine, U.S. Security Cooperation and Assistance, U.S. Strategy in the Indo-Pacific Region (no bill).

H.R. 6443, Arm Taiwan Act of 2022, all provisions. H.R. 7330, Keeping Israel Safe from Iranian Proxies Act, all provisions. S. 3131, "Arm Taiwan Act of 2021," all provisions. Issues related to Abraham Accords, Chinas Military Strategy and Capabilities, Chinese Influence Operations, Chinese Military-Civil Fusion Strategy, Global War on Terror, Great Power Competition with Russia and China, Implementation of Requirement to Identify Chinese Military Companies Operating in the United States, Implementation of the Sanctioning the Use of Civilians as Defenseless Shields Act, Iran Sanctions, Irans Military Strategy and Capabilities, Iran's Foreign Policy, Palestinian Politics and Terrorism, Terror Groups' Use of Human Shields, U.S. Arms Sales, U.S. Basing Overseas, U.S. Cybersecurity Strategy and Capabilities, U.S. Defense Supply Chain, U.S. Military Capabilities and Strategy, U.S. Military Exercises in the Indo-Pacific, U.S. Military Exercises in the Middle East, U.S. Policy on China, U.S. Policy on Hezbollah, U.S. Policy on Iran, U.S. Policy on Iraq, U.S. Policy on Israel, U.S. Policy on North Korea, U.S. Policy on Russia, U.S. Policy on Taiwan, U.S. Policy on Ukraine, U.S. Policy on Yemen, U.S. Security Cooperation and Assistance, U.S. Strategy in Africa, and U.S. Strategy in the Indo-Pacific Region (no bill).

Client expense: $40,000 · Firm income: Not reported